The new findings come from a 15-year study examining the natural course of C-peptide in children and adolescents with type 1 diabetes (T1D). A marker of pancreatic function in patients with diabetes ...

What Is C-Peptide? Why It’s Done How It’s Performed What’s Next The C-peptide test is a way of estimating how much of the hormone insulin your body creates. This test can help doctors determine what ...

This randomized, multicenter study of children and adolescents with new-onset type 1 diabetes (T1D) investigated the effect on glucose control of a closed-loop system, using C-peptide levels to gauge ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Young people with new type 1 diabetes had higher ...

Whether improved glucose control with hybrid closed-loop therapy can preserve C-peptide secretion as compared with standard insulin therapy in persons with new-onset type 1 diabetes is unclear. A ...

C-peptide, a 31–amino acid peptide originally regarded as an inert by‐product of insulin synthesis, is emerging as a key modulator of diabetic complications. Secreted in equimolar amounts with insulin ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Recombinant human glutamic acid decarboxylase formulated ...

Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels This sub-analysis is the first study to evaluate ...

The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type 1 diabetes, 2-year data from the phase II BANDIT trial showed. After ...

“A benefit of AID is present with high C-peptide levels and low C-peptide levels. Thus, requiring a low C-peptide level as a prerequisite for AID therapy is not warranted,” the authors wrote. The ...